Shares of Apollo Hospitals hogged the limelight in commerce on Wednesday, February 12, and rose 3% forward of the dividend document date this week.
The Nifty 50 hospital inventory on Monday, together with its quarterly earnings, introduced an interim dividend of ₹9 per share.
“The Board of Administrators declared an interim dividend of Rs. 9/- per share (180% of face worth of Rs. 5/- per share) for the monetary 12 months ending thirty first March 2025, on the paid-up fairness shares, out of the income of the Firm,” Apollo Hospitals acknowledged in a submitting.
The corporate additional fastened February 15 because the document date for the aim of the cost of the mentioned interim dividend. This implies, the dividend will probably be paid to the fairness shareholders, whose names seem within the register of members/useful house owners of the corporate as on February 15.
As per the submitting, Apollo Hospitals pays the mentioned interim dividend on or earlier than February 28.
Apollo Hospital Inventory Worth Pattern
Shares of Apollo Hospitals rebounded on Wednesday, following their slide to 6-month low. The inventory rose as a lot as 2.86% to ₹6,496.10 per share on the BSE at the moment.
With at the moment’s rise, Apollo Hospitals share worth has snapped its four-day dropping run.
Apollo Hospitals Q3 Present
For Q3 FY25, Apollo Hospitals reported a 14% year-on-year (YoY) progress in income to ₹5,527 crore. Its consolidated revenue after tax (PAT) surged 52% YoY to ₹372 crore, in comparison with ₹245 crore in Q3 FY24. Consolidated EBITDA for the quarter grew 24% YoY to ₹762 crore.
As of December 31, 2024, Apollo Hospitals operated 7,996 beds throughout its community (excluding AHLL and managed beds). The general occupancy fee stood at 68%, in comparison with 66% in the identical interval the earlier 12 months, pushed by a major rise in affected person flows, in keeping with the corporate’s Q3 earnings report.
Brokerage Motilal Oswal Monetary Providers (MOSL) mentioned Apollo Hospitals Enterprises (APHS) delivered an in-line efficiency for 3QFY25. “APHS noticed broad-based progress throughout hospitals, Healthco (on-line/offline pharmacy), and the Well being and Way of life (AHLL) phase. The corporate reported wholesome progress in realization per affected person and the variety of sufferers handled. The GMV remained secure on a sequential foundation,” it added.
Nonetheless, the brokerage lowered earnings estimates by 4%/5% for FY26/FY27, factoring moderately in GMV for Apollo 24/7 and a rise in working bills associated to the commissioning of newer hospitals. It additionally revised its goal worth decrease to ₹7,800 whereas sustaining a ‘purchase’ ranking.
Disclaimer: The views and suggestions above are these of particular person analysts or broking corporations, not Mint. We advise buyers to examine with licensed specialists earlier than making any funding selections.
